Publications by authors named "Ole Suhr"

Claim this Profile
P
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study.
Ole B Suhr, Martha Grogan, Ana Martins da Silva, Chafic Karam, Pablo Garcia-Pavia

Amyloid· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?].
Jonas Wixner, Intissar Anan, Björn Pilebro, Erica Uneus, Jorge Mejia Baranda, Ole Suhr

Lakartidningen· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis.
Intissar Anan, Ole B Suhr, Katarzyna Liszewska, Jorge Mejia Baranda, Björn Pilebro

PLoS One· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebellar and Cerebral Amyloid Visualized by [F]flutemetamol PET in Long-Term Hereditary V30M () Transthyretin Amyloidosis Survivors.
Erica Irene Uneus, Christer Wilhelmsson, David Bäckström, Intissar Anan, Jonas Wixner, Ole B Suhr

Front Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Thibaud Damy, Arnt V Kristen, Ole B Suhr, Mathew S Maurer, Violaine Planté-Bordeneuve

Eur Heart J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Viktor Löfbacka, Ole B Suhr, Bjorn Pilebro, Jonas Wixner, Torbjorn Sundström

Clin Physiol Funct Imaging· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
David Adams, Yukio Ando, João Melo Beirão, Teresa Coelho, Morie A Gertz, Ole B Suhr

J Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac transthyretin amyloidosis Tc-DPD SPECT correlates with strain echocardiography and biomarkers.
Viktor Löfbacka, Jan Axelsson, Björn Pilebro, Ole B Suhr, Per Lindqvist

Eur J Nucl Med Mol Imaging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.
Radislav Nakov, Ole B Suhr, Gianluca Ianiro, Juozas Kupcinskas, Jonathon P Segal

Eur J Gastroenterol Hepatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.
Aubin Michalon, Andreas Hagenbuch, Christian Huy, Evita Varela, Benoit Combaluzier, Ole B Suhr

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.
Hedvig Paulsson Rokke, Nima Sadat Gousheh, Per Westermark, Ole B Suhr, Intissar Anan

Orphanet J Rare Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study.
Jenny Pagoldh, David Lundgren, Ole B Suhr, Pontus Karling

Gastroenterol Rep (Oxf)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of cardiac amyloid with [F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis.
Sofia Möckelind, Jan Axelsson, Björn Pilebro, Per Lindqvist, Ole B Suhr

Amyloid· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
Morie Gertz, David Adams, Yukio Ando, João Melo Beirão, Sabahat Bokhari, Ole B Suhr

BMC Fam Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.
Teresa Coelho, David Adams, Isabel Conceição, Márcia Waddington-Cruz, Hartmut H Schmidt, Ole B Suhr

Orphanet J Rare Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response: concerning "late early and late onset" ATTR Val30Met patients.
Ole B Suhr

Amyloid· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
Ole Bernt Suhr, Jonas Wixner, Intissar Anan, Hans-Erik Lundgren, Priyantha Wijayatunga

PLoS One· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.
Laura Obici, Ole B Suhr

Clin Auton Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary to Isabel Conceição et al. early diagnosis through targeted follow-up of identified carriers of TTR gene mutations.
Ole B Suhr

Amyloid· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Scott D Solomon, David Adams, Arnt Kristen, Martha Grogan, Alejandra González-Duarte, Ole Suhr

Circulation· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right ventricular involvement in transthyretin amyloidosis.
Sandra Arvidsson, Michael Y Henein, Gerhard Wikström, Ole B Suhr, Per Lindqvist

Amyloid· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
David Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, Chih-Chao Yang, Mitsuharu Ueda, Ole B Suhr

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
Michael Y Henein, Ole B Suhr, Sandra Arvidsson, Björn Pilebro, Per Westermark

Amyloid· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal scores of deep breathing tests: beware of dysrhythmia in transthyretin amyloidosis.
Urban Wiklund, Amir Kadkhodaee, Kennet Andersson, Ole B Suhr, Rolf Hörnsten

Amyloid· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational study.
Aghil Ibrahim, Per Dahlqvist, Tommy Olsson, David Lundgren, Mårten Werner, Ole B Suhr

Therap Adv Gastroenterol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis